Search Results - "Salpeter, E"

Cardioselective beta-blockers for chronic obstructive pulmonary disease by Salpeter, S, Ormiston, T, Salpeter, E

“…Beta-blocker therapy has a proven mortality benefit in patients with hypertension, heart failure and coronary artery disease, as well as during the…”
Get more information

Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women by Salpeter, S. R., Walsh, J. M. E., Ormiston, T. M., Greyber, E., Buckley, N. S., Salpeter, E. E.

“…Aim:  To quantify the effects of hormone‐replacement therapy (HRT) on components of the metabolic syndrome in postmenopausal women. Methods:  Comprehensive…”
Get full text

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus by Salpeter, S, Greyber, E, Pasternak, G, Salpeter, E

“…Metformin is an oral anti-hyperglycemic agent used in the treatment of type 2 diabetes mellitus. The results of the UK Prospective Diabetes Study indicate that…”
Get more information

Bayesian Meta-analysis of Hormone Therapy and Mortality in Younger Postmenopausal Women by Salpeter, Shelley R., MD, Cheng, Ji, MSc, Thabane, Lehana, PhD, Buckley, Nicholas S, Salpeter, Edwin E., PhD (Posthumous)

“…Abstract Background There is uncertainty over the risks and benefits of hormone therapy. We performed a Bayesian meta-analysis to evaluate the effect of…”
Get full text

Meta-analysis: Metformin Treatment in Persons at Risk for Diabetes Mellitus by Salpeter, Shelley R., MD, Buckley, Nicholas S, Kahn, Justin A, Salpeter, Edwin E., PhD

“…Abstract Purpose We performed a meta-analysis of randomized controlled trials to assess the effect of metformin on metabolic parameters and the incidence of…”
Get full text

Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis by Salpeter, Shelley R, Ormiston, Thomas M, Salpeter, Edwin E

“…beta-Adrenergic agonists exert physiologic effects that are the opposite of those of beta-blockers. beta-Blockers are known to reduce morbidity and mortality…”
Get more information

BRIEF REPORT: Coronary Heart Disease Events Associated with Hormone Therapy in Younger and Older Women by Salpeter, Shelley R., Walsh, Judith M. E., Greyber, Elizabeth, Salpeter, Edwin E.

“…OBJECTIVE: To assess the effect of hormone therapy (HT) on coronary heart disease (CHD) events in younger and older postmenopausal women. DESIGN: A…”
Get full text

Cardioselective β-blockers in patients with reactive airway disease: A meta-analysis by SALPETER, Shelley R, ORMISTON, Thomas M, SALPETER, Edwin E

“…To assess the effect of cardioselective beta-blockers on respiratory function of patients with reactive airway disease. Comprehensive searches of the EMBASE,…”
Get full text

Mortality associated with Hormone replacement therapy in younger and older women: A meta-analysis by SALPETER, Shelley R, WALSH, Judith M. E, GREYBER, Elizabeth, ORMISTON, Thomas M, SALPETER, Edwin E

“…To assess mortality associated with hormone replacement in younger and older postmenopausal women. A comprehensive search of MEDLINE, CINAHL, and EMBASE…”
Get full text

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus by Salpeter, S, Greyber, E, Pasternak, G, Salpeter, E

“…Metformin is an oral anti-hyperglycemic agent used in the treatment of type 2 diabetes mellitus. The results of the UK Prospective Diabetes Study indicate that…”
Get more information

Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis by Salpeter, S.R, Ormiston, T.M, Salpeter, E.E, Poole, P.J, Cates, C.J

“…Beta-blocker therapy has a mortality benefit in patients with hypertension, heart failure and coronary artery disease, as well as during the perioperative…”
Get full text

The Cost-effectiveness of Hormone Therapy in Younger and Older Postmenopausal Women by Salpeter, Shelley R., MD, Buckley, Nicholas S, Liu, Hau, MD, MBA, Salpeter, Edwin E., PhD

“…Abstract Purpose To evaluate the health and economic outcomes of hormone therapy in younger and older postmenopausal women. Methods We developed a…”
Get full text

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus by Salpeter, Shelley R, Greyber, Elizabeth, Pasternak, Gary A, Salpeter, Edwin E

“…Metformin is an oral anti-hyperglycemic agent that has been shown to reduce total mortality compared to other anti-hyperglycemic agents, in the treatment of…”
Get more information

Cardioselective beta-blockers for chronic obstructive pulmonary disease by Salpeter, S S, Ormiston, T, Salpeter, E, Poole, P, Cates, C

“…Beta-blocker therapy has a proven mortality benefit in patients with hypertension, heart failure and coronary artery disease, as well as during the…”
Get more information

Meta-analysis : Effect of long-acting β-agonists on severe asthma exacerbations and asthma-related deaths by SALPETER, Shelley R, BUCKLEY, Nicholas S, ORMISTON, Thomas M, SALPETER, Edwin E, GLASSROTH, Jeffrey

“…Long-acting beta-agonists may increase the risk for fatal and nonfatal asthma exacerbations. To assess the risk for severe, life-threatening, or fatal asthma…”
Get full text

Monitored Isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age : A risk-benefit and cost-effectiveness analysis by SALPETER, S. R, SANDERS, G. D, SALPETER, E. E, OWENS, D. K

“…Isoniazid chemoprophylaxis effectively prevents the development of active infectious tuberculosis. Current guidelines recommend withholding this prophylaxis…”
Get full text

Mathematical Model for the Epidemiology of Tuberculosis, with Estimates of the Reproductive Number and Infection-Delay Function by Salpeter, Edwin E., Salpeter, Shelley R.

“…The authors used epidemiologic data on tuberculosis to construct a model for the time delay from initial latent infection to active disease, when infection…”
Get full text

Screening and Treatment of Latent Tuberculosis Among Healthcare Workers at Low, Moderate, and High Risk for Tuberculosis Exposure: A Cost‐Effectiveness Analysis by Salpeter, Shelley R., Salpeter, Edwin E.

“…To evaluate cost-effective screening and treatment strategies for healthcare workers (HCWs) at risk for tuberculosis exposure. A Markov model was developed to…”
Get full text

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus by Salpeter, Shelley R, Greyber, Elizabeth, Pasternak, Gary A, Salpeter Posthumous, Edwin E

“…Metformin is an oral anti-hyperglycemic agent that has been shown to reduce total mortality compared to other anti-hyperglycemic agents, in the treatment of…”
Get more information

Gene Expression Profiles as Predictors of Poor Outcomes in Stage II Colorectal Cancer: A Systematic Review and Meta-analysis by Lu, An-Ting T, Salpeter, Shelley R, Reeve, Anthony E, Eschrich, Steven, Johnston, Patrick G, Barrier, Alain J, Bertucci, Francois, Buckley, Nicholas S, Salpeter, Edwin E, Lin, Albert Y

“…Abstract Purpose The use of adjuvant therapy in stage II colorectal cancer (CRC) remains controversial. There is a need to identify more effective predictors…”
Get full text